Global Gout Treatment Market - Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Sep 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Gout Treatment Market By Type (Tophaceous Gout, Pseudogout Gout), Diagnosis Type (X-ray, CT Scan, Ultrasound and Others), Treatment Type (Medication, Surgery, Others), Drugs Type (Allopurinol, Febuxostat, Peobenecid, Indomethacin and Others), Route of Administration (Oral, Injectable, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Gout Treatment Market

Global gout treatment market is rising gradually with a healthy CAGR of 12.6% in the forecast period of 2019-2026. The increasing prevalence of gout by increase of obesity and pediatric patients is likely to drive the global gout treatment market. Due to increase in prevalence of chronic gout, Asia pacific countries are expected to have a fastest growing gout treatment market.

Market Definition: Global Gout Treatment Market

Gout is a common type of arthritis that is caused by abnormal metabolism of uric acid that causes deposition of uric acid in joints. Gout is characterized by sudden, intense pain, swelling, redness and stiffness in joints. There are four stages of gout, asymptomatic hyperuricemia, acute gout, or a gout attack, interval gout and chronic gout.

According to an article published in journal of Arthritis Rheumatol.  in June 2019 , the prevalence of gout was approximately 3.9% in adults in an estimated population of 9.2 million people of US with 5.2% of ratio affecting the male population and  2.7% of ratio affecting the female population. T The introduction of biologics and development of newer therapies for the treatment of gout drives the global gout treatment market.

Market Drivers

  • Increasing aging population are more vulnerable for gout which can augment the market growth
  • Increasing adoption of newer therapies and advanced treatment can act as a market driver
  • Prevailing cases of obesity can also drive the market growth
  • Increasing number of passive smokers along with adoption of sedentary lifestyle can also enhance the growth of this market

Market Restraints

  • Lack of awareness about symptoms and disease restrains the gout treatment market
  • Patent expiry of blockbuster drugs can also hinder this market growth
  • Stringent regulation also acts as a major restraining factor for the market growth

Segmentation: Global Gout Treatment Market

By Type

  • Tophaceous Gout
  • Pseudogout

By Diagnosis Type

  • X-ray
  • CT Scan
  • Ultrasound
  • Others

By Treatment

  • Medication
  • Surgery
  • Others

By Drugs Types

  • Allopurinol
  • Febuxostat
  • Probenecid
  • Indomethacin
  • Others

By Route of Administration

  • Oral
  • Injectable
  • Others

By End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific

  • Middle East & Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In May 2019, Horizon Therapeutics plc announced the launch of Gout Lies, a data-driven campaign to reframe physician dialogue on the reality of living with gout and highlight the newer developments in proper treatment of gout. The campaign also highlights the consequences of inadequate management including bone erosion, joint damage among others
  • In August 2018, Grünenthal received marketing authorization for the EU/EEA for Duzallo from European Commission. Duzallo is a fixed-dose combination (FDC) of allopurinol and lesinurad that is used for the treatment of hyperuricaemia in adult gout patients. The Committee for Medicinal Products for Human Use (CHMP) reported positive opinion on use of Duzallo and authorized the marketing of the FDC. With this approval there is a potential to help improving the control of uric acid serum levels and enhancing the quality of life

Competitive Analysis:

Global gout treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global Gout treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in the global gout treatment market are Takeda Pharmaceutical Company Limited, Mylan N.V., ALLERGAN, Sun Pharmaceutical Industries Ltd., Vintage Labs, Ipca Laboratories Ltd., INDOCO REMEDIES LTD., Zydus Cadila, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Casper Pharma, Alembic Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC., Novartis AG, Flexion Therapeutics Inc,  Antares Pharma among others.

Research Methodology: Global Gout Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global gout treatment market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions